Login

Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors 00:10:00

Share On Facebook Share On Twitter

Rene Bruner is the CFP and Advisor of smith bruer advisors

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Women Are Natural Problem Solvers|Susan Lyne,Managing Partner and Co-Founder,BBG Ventures
00:00:00
Well-recognized leader in Pathology and Immunology education/Andrew Lichtman, MD, PhD Professor of Pathology at Harvard Medical School
00:10:00
A General Guide to IRS Audits | Vince Carson - Tax Specialist at Howe & Rusling
00:10:00
Driving Burlingame’s Future: Insights on Business Growth from Local Leaders | Lisa Goldman - City Manager, Burlingame
00:10:00
Introduction to Endowment Wealth Management | Robert L. Riedl, CEO , Endowment Wealth Management, Inc.
00:10:00
Health & Wealth: Aligning Personal Well-being with Financial Planning
00:10:00
BrightView Landscape CEO Andrew Masterman Addresses Inflation Impact on Company Costs
00:10:00
The Innovation Engine: How New Industries Spark Productivity, Creativity, and Global Transformation|Casey Aylward,Partner,Accel
00:10:00
Tilaknagar Industries' Financial Turnaround: Chairman Amit Dhanuka on Overcoming Stress and Achieving Profitability|Amit Dahanukar,Chairman and Managing Director,Tilaknagar Industries Ltd.
00:10:00
Overview of Unigold: Exploring Opportunities in the Dominican Republic
00:10:00
Business Rockstars Interview with #NXTID CEO Gino Pereira | Chia-Lin Simmons, CEO of NXT ID Inc
00:10:00
Claire Berlinski on Margaret Thatcher's Resolve and Reforms|Claire Berlinski

© 2026 Nehu